LinkedInJan Voskuil

Jan Voskuil

CSO at Everest Biotech

Oxford, United Kingdom
  1. Everest Biotech Ltd
  1. Proimmune Ltd,
  2. Central Laboratory Services, Huntingdon,
  3. Huntingdon Life Sciences, Huntingdon
  1. University of Oxford

Join LinkedIn & access Jan's full profile

Join LinkedIn & access Jan's full profile. It's free!

As a LinkedIn member, you'll join 300 million other professionals who are sharing connections, ideas, and opportunities.

  • See who you know in common
  • Get introduced
  • Contact Jan directly
Everest Biotech Ltd

Everest Biotech Ltd

Chief Scientific Officer, Teamleader Production Development and QC

– Present

View full profile



Driving force behind the ever growing size and quality of the Everest Biotech antibody catalogue and an active expert member in discussions in relevant LinkedIn discussion groups. Direct contact as CSO for custom antibody services and for technical support. Writer of all content in the technical support web pages of Everest Biotech. Active in the world of Biomarkers. Through thorough reputation building the company transformed to a profit-generating enterprise with increasing frequency and amounts of dividends.

Latest publication:
Commercial antibodies and their validation.
Web blogs:
Non-specific binding, background and noise (
Peptide polyclonal antibodies as an alternative to monoclonal antibodies (mabs) (
How to validate an antibody? (
The troubles with commercial research antibodies dissected (

April 2014: 5th International Conference on Biomarkers & Clinical Research, Oxford, UK
October 2014: 1st International Antibody Validation Forum, London, UK
April 2015: 7th Annual International Congress of Antibodies, Nanjing, China


Chief Scientific Officer, Teamleader Production Development and QC

Everest Biotech Ltd
– Present (10 years)

• Bearing end-responsibility for the technical procedures at the production facilities
• Introducing and implementing process improvements
• Providing technical training
• Introducing and writing formal Standard Operation Procedures (SOP)
• Identifying new leads to serve as targets for new products
• Design and redesign peptides for antibodies against the best leads
• Commissioning QC experiments in Western blot
• Passing and failing new antibody products based on Western blot results
• Introducing Immunohistochemistry (IHC) as a new QC measure
• Passing and failing antibody products based on IHC results
• Keeping close relationships with academic collaborators to further characterize our products.
• Keeping records of monthly production figures and presenting to the board
• Preparing and implementing capacity enlargements in the production
• Reassessments of older products to either update the datasheet or to withdraw from the market
• Providing technical support to direct customers and OEM business partners
• Introducing and adding content to the technical support web pages

QC consultant

Proimmune Ltd
(less than a year)

• Flow Cytometry and ELISA for QC purposes
• Writing analysis reports

Senior Technical Specialist

Central Laboratory Services, Huntingdon
(less than a year)

• Evaluating approach on 510(k) method validation assessments
• Strategy development to convert RIA to EIA in compliance with 510(k)
• Writing SOP for method validation for quantitative analysis of PK/PD markers in compliance with FDA/AAPS guidelines
• Writing SOP for quasi-quantitative analysis, for semi-quantitative analysis, and for qualitative analysis
• Writing SOP for diagnostic analysis of thyroid markers in EIA.

Senior Study Manager

Huntingdon Life Sciences, Huntingdon
(less than a year)

• Quantitative analysis in matrices by RIA and ELISA in a GLP environment
• Archiving updated Standard Operation Procedures
• Writing analytical reports for clients

Senior Scientist

Synaptica Ltd
(2 years)

• Management of technical assistants. Training and confidence building.
• Identification of putative endogenous ligand. Assay development and detection of a new oligomeric species at very low abundance.
• Validation of diagnostic assays. Detecting protein-peptide interactions, distinguishing Alzheimer’s disease from controls. Work resulted in a patent.

Honors & Awards

Member of advisory board for antibody validation collection




A new platform to bring together pharma industries, diagnostic industries, biotech industries, clinicians, academia and multimedia.

Team members:


LinkedIn Antibody Troubleshoot Forum

– Present

LinkedIn The Wider Scientists Community

– Present


  1. Dutch

    Native or bilingual proficiency
  2. English

    Full professional proficiency
  3. German

    Limited working proficiency


  • See...
  • Molecular Biology
  • Flow Cytometry
  • Assay Development
  • GLP
  • Western Blotting
  • Immunohistochemistry
  • Antibodies
  • Validation
  • Biotechnology
  • Lifesciences
  • Biochemistry
  • Protein Chemistry
  • Protein Expression
  • Immunology
  • Immunoassays
  • Biomarkers
  • Genomics
  • Cell Biology
  • Cell
  • Cell Culture
  • Monoclonal Antibodies
  • Purification
  • Drug Discovery
  • Genetics
  • Bioinformatics
  • Life Sciences
  • See 13+  See less


University of Oxford

postdoc, Neurodegeneration

View Jan's full profile to...

  • See who you know in common
  • Get introduced
  • Contact Jan directly

Not the Jan Voskuil you're looking for? View more


People Also Viewed

LinkedIn members in United Kingdom:

  1. a
  2. b
  3. c
  4. d
  5. e
  6. f
  7. g
  8. h
  9. i
  10. j
  11. k
  12. l
  13. m
  14. n
  15. o
  16. p
  17. q
  18. r
  19. s
  20. t
  21. u
  22. v
  23. w
  24. x
  25. y
  26. z
  27. more